Stock 000915 SHANDONG WIT DYNE HEALTH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shandong Wit Dyne Health Co.,Ltd.

Equities

000915

CNE000000Z28

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
35.74 CNY +0.06% Intraday chart for Shandong Wit Dyne Health Co.,Ltd. +1.25% +23.41%
Apr. 17 Shandong Wit Dyne Health Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 18 Shandong Wit Dyne Health Co.,Ltd. Proposes Final Cash Dividend for the Year 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,210 5,481 7,138 10,662 6,786 8,375 - -
Enterprise Value (EV) 1 6,210 5,481 7,138 10,662 6,786 8,375 8,375 8,375
P/E ratio 30.5 x 18.7 x 18.8 x 20.2 x 11.6 x 12.5 x 11 x 9.71 x
Yield 1.13% 1.5% 2.63% - 6.91% - - -
Capitalization / Revenue 3.45 x 3.01 x 3.52 x 4.55 x 2.73 x 2.98 x 2.64 x 2.36 x
EV / Revenue 3.45 x 3.01 x 3.52 x 4.55 x 2.73 x 2.98 x 2.64 x 2.36 x
EV / EBITDA - - - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 3.59 x 2.8 x 3.26 x 4.13 x 2.28 x 2.63 x 2.46 x 2.29 x
Nbr of stocks (in thousands) 234,331 234,331 234,331 234,331 234,331 234,331 - -
Reference price 2 26.50 23.39 30.46 45.50 28.96 35.74 35.74 35.74
Announcement Date 3/6/20 1/15/21 1/18/22 1/19/23 1/20/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,800 1,820 2,027 2,341 2,484 2,809 3,169 3,556
EBITDA - - - - - - - -
EBIT 1 414.2 612.7 818.1 1,160 1,326 1,520 1,728 1,952
Operating Margin 23.01% 33.67% 40.36% 49.56% 53.37% 54.11% 54.53% 54.89%
Earnings before Tax (EBT) 1 414.4 619.7 821.1 1,159 1,325 1,519 1,727 1,951
Net income 1 204.1 292.3 380.3 526.9 585.3 671 763 862
Net margin 11.34% 16.06% 18.76% 22.51% 23.56% 23.89% 24.08% 24.24%
EPS 2 0.8700 1.250 1.620 2.250 2.500 2.860 3.250 3.680
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 0.3000 0.3500 0.8000 - 2.000 - - -
Announcement Date 3/6/20 1/15/21 1/18/22 1/19/23 1/20/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 12.3% 15.9% 18.1% 22.1% 21.1% 21.1% 22.4% 23.5%
ROA (Net income/ Total Assets) 6.75% 8.49% 9.98% - - - - -
Assets 1 3,026 3,442 3,810 - - - - -
Book Value Per Share 2 7.390 8.340 9.340 11.00 12.70 13.60 14.60 15.60
Cash Flow per Share 2 1.040 3.140 2.710 5.110 5.010 5.380 6.160 6.900
Capex 172 - 120 - 48.7 - - -
Capex / Sales 9.58% - 5.93% - 1.96% - - -
Announcement Date 3/6/20 1/15/21 1/18/22 1/19/23 1/20/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shandong Wit Dyne Health Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.74
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG WIT DYNE HEALTH CO.,LTD. Stock Shandong Wit Dyne Health Co.,Ltd.
+23.41% 1.16B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000915 Stock
  4. Financials Shandong Wit Dyne Health Co.,Ltd.